Table 1.
Variables | No. and (%) |
---|---|
HCC patients | |
No. of patients | 188 |
Age (median; range), years | 50; 13–76 |
Gender (male/female) | 159/29 (84.6/15.4) |
HBV infection (no/yes) | 19/169 (10.1/89.9) |
Alpha-fetoprotein, ng/mL (≤2 5/>25) | 74/114 (39.4/60.6) |
Child–Pugh class (A/B) | 175/13 (93.1/6.9) |
Tumor number (single/multiple) | 144/44 (76.6/23.4) |
Tumor size, cm (≤5/>5) | 80/108 (42.6/57.4) |
Vascular invasion (absent/present) | 177/11 (94.1/5.9) |
TNM stage (I/II/III) | 130/16/39 (69.1/10.1/20.8) |
Histological grade (I/II/III/other) | 125/63 (66.5/33.5) |
GC patients | |
No. of patients | 138 |
Age (median; range), years | 69; 28–78 |
Gender (male/female) | 100/38 (72.5/27.5) |
Tumor size, cm (≤4/>4) | 46/92 (33.3/66.7) |
Tumor depth (pT1/pT2/pT3/pT4) | 3/10/34/91 (2.2/7.2/24.7/65.9) |
Lymph node metastasis (pN0/pN1/pN2/pN3) | 29/31/27/51 (21.0/22.5/19.5/37.0) |
TNM stage (IA/IB/II/IIIA/IIIB/IIIC) | 3/6/5/25/32/32/35 (2.2/4.3/3.6/18.1/23.2/23.2/25.4) |
Histological grade (I/II/III/other) | 3/32/90/11 (2.2/23.2/65.2/8.0) |
HCC hepatocellular carcinoma, GC gastric cancer, HBV hepatitis B virus, TNM tumor-lymph node-metastasis